INMODE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.41 USD | +0.40% |
|
-1.58% | -21.72% |
| Apr. 12 | Barclays Adjusts Price Target on InMode to $33 From $34, Maintains Overweight Rating | MT |
| Apr. 09 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
Financials (USD)
| Sales 2024 * | 492M | Sales 2025 * | 534M | Capitalization | 1.47B |
|---|---|---|---|---|---|
| Net income 2024 * | 199M | Net income 2025 * | 216M | EV / Sales 2024 * | 0.93 x |
| Net cash position 2024 * | 1.01B | Net cash position 2025 * | 1.27B | EV / Sales 2025 * | 0.36 x |
| P/E ratio 2024 * |
7.51
x | P/E ratio 2025 * |
6.96
x | Employees | 581 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.25% |
More Fundamentals
* Assessed data
More news
Latest transcript on InMode Ltd.
More recommendations
More press releases
| 1 day | +0.40% | ||
| 1 week | -2.85% | ||
| Current month | -19.44% | ||
| 1 month | -15.44% | ||
| 3 months | -22.93% | ||
| 6 months | -12.34% | ||
| Current year | -21.72% |
1 week
16.96
18.07
1 month
16.9621.92
Current year
16.9626.80
1 year
16.9648.25
3 years
16.9699.27
5 years
6.5399.27
10 years
6.5399.27
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Kreindel
FOU | Founder | 57 | 08-01-01 |
Moshe Mizrahy
CEO | Chief Executive Officer | 71 | 08-01-01 |
Yair Malca
DFI | Director of Finance/CFO | 46 | 16-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bruce Mann
BRD | Director/Board Member | 89 | 19-08-06 |
Moshe Mizrahy
CEO | Chief Executive Officer | 71 | 08-01-01 |
Michael Kreindel
FOU | Founder | 57 | 08-01-01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.54% | 5 M€ | -1.80% | - | |
| 0.10% | 12 M€ | -.--% | - | |
| 0.10% | 18 M€ | +1.40% | - | |
| 0.05% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 17.34 | -0.63% | 1,504,704 |
| 24-04-17 | 17.45 | -0.96% | 946,631 |
| 24-04-16 | 17.62 | -0.40% | 1,279,080 |
| 24-04-15 | 17.69 | -1.28% | 2,195,951 |
| 24-04-12 | 17.92 | -2.98% | 1,865,638 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women's health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Calendar
2024-05-01
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
17.34
USD
Average target price
27.6
USD
Spread / Average Target
+59.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -21.72% | 1.47B | |
| +2.64% | 207B | |
| +1.80% | 175B | |
| +8.59% | 132B | |
| +16.47% | 99.1B | |
| -3.42% | 60.89B | |
| +12.71% | 52.04B | |
| -6.61% | 45.48B | |
| -4.53% | 38.81B | |
| +9.27% | 38.77B |
- Stock Market
- Equities
- INMD Stock
